Waystar Holding Corp. (WAY) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated Jun 12, 2026
Current Price
$18.75
Price Target
$35.62
Target Range
$27.00 — $43.00
Analyst Rating
Buy
Forward P/E11.4x
Trailing P/E30.7x
Forward PEG—
Implied Growth+154.1%
Median Target$36.00
Analyst Spread44.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$27
+44.0%
Consensus
$36
+90.0%
Bull Case
$43
+129.3%
Valuation Model TargetsConfidence: 66/100
Bear$25
Base$35
Bull$42
WAY Price Target Analysis
Updated June 13, 2026As of June 13, 2026, Waystar Holding Corp. (WAY) has a Wall Street consensus price target of $35.62, based on estimates from 17 covering analysts. With the stock currently trading at $18.75, this represents a potential upside of +90.0%. The company has a market capitalization of $3.60B.
Analyst price targets range from a low of $27.00 to a high of $43.00, representing a 45% spread in expectations. The median target of $36.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 17 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, WAY trades at a trailing P/E of 30.7x and forward P/E of 11.4x. Analysts expect EPS to grow +154.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $35.01, with bear and bull scenarios of $24.51 and $42.01 respectively. Model confidence stands at 66/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Technology stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+35.9%
Avg Forward P/E14.3x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NVCRNovoCure Limited | $2.0B | $17.78 | $33.50 | +88.4% | Buy | — | 15 |
 COLLCollegium Pharmaceutical, Inc. | $1.1B | $34.64 | $58.00 | +67.4% | Buy | 4.5x | 12 |
 MTEXMannatech, Incorporated | $11M | $5.50 | — | — | — | — | — |
 VEEVVeeva Systems Inc. | $25.9B | $159.54 | $235.38 | +47.5% | Buy | 17.6x | 43 |
 HIMSHims & Hers Health, Inc. | $5.9B | $26.82 | $27.00 | +0.7% | Hold | — | 20 |
 AMSFAMERISAFE, Inc. | $593M | $31.53 | $44.50 | +41.1% | Buy | 15.0x | 6 |
 CXDOCrexendo, Inc. | $235M | $7.24 | $11.50 | +58.8% | Buy | 17.2x | 6 |
 UNHUnitedHealth Group Incorporated | $370.8B | $408.52 | $418.50 | +2.4% | Buy | 22.2x | 52 |
 CVSCVS Health Corporation | $130.1B | $101.96 | $103.64 | +1.6% | Buy | 13.8x | 41 |
 CICigna Corporation | $78.6B | $298.00 | $342.55 | +14.9% | Buy | 9.8x | 39 |
Upside Potential Comparison
NVCRCOLLCXDOVEEVAMSFCIUNHCVSWhat if you invested $1,000 in WAY 10 years ago?
Total return calculator · dividends reinvested
Calculate ReturnsHow much would $100/month in WAY be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs WAY Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationWAY vs NVDA — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs NVIDIA Corporation.
Compare NowWAY — Frequently Asked Questions
Quick answers to the most common questions about buying WAY stock.
What is the WAY stock price target for 2026?
The consensus Wall Street price target for WAY is $35.62, representing 90.0% upside from the current price of $18.75. With 17 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is WAY a buy, sell, or hold?
WAY has a consensus rating of "Buy" based on 17 Wall Street analysts. The rating breakdown is predominantly bullish, with 17 Buy/Strong Buy ratings. The consensus 12-month price target of $35.62 implies 90.0% upside from current levels.
Is WAY stock overvalued or undervalued?
With a forward P/E of 11.419x, WAY trades at a relatively low valuation. The consensus target of $35.62 implies 90.0% appreciation, suggesting meaningful undervaluation.
How high can WAY stock go?
The most bullish Wall Street analyst has a price target of $43 for WAY, while the most conservative target is $27. The consensus of $35.62 represents the median expectation. Our quantitative valuation model projects a bull case target of $42 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover WAY stock?
WAY is well covered by analysts, with 17 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 16 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the WAY stock forecast?
The 12-month WAY stock forecast based on 17 Wall Street analysts shows a consensus price target of $35.62, with estimates ranging from $27 (bear case) to $43 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $35, with bear/bull scenarios of $25/$42.
What is WAY's fair value based on fundamentals?
Our quantitative valuation model calculates WAY's fair value at $35 (base case), with a bear case of $25 and bull case of $42. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 66/100.
What is WAY's forward P/E ratio?
WAY trades at a forward P/E ratio of 11.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 30.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy WAY stock?
Wall Street analysts are very optimistic on WAY, with a "Buy" consensus rating and $35.62 price target (90.0% upside). 17 of 17 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do WAY price targets vary so much?
WAY analyst price targets range from $27 to $43, a 45% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $35.62 consensus represents the middle ground. Our model's $25-$42 range provides an independent fundamental perspective.